These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26969377)

  • 1. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of growth inhibitory response of Resveratrol and Salinomycin combinations against triple negative breast cancer cells.
    Rai G; Suman S; Mishra S; Shukla Y
    Biomed Pharmacother; 2017 May; 89():1142-1151. PubMed ID: 28298074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway.
    Hajra S; Patra AR; Basu A; Saha P; Bhattacharya S
    Chem Biol Interact; 2018 Jun; 290():19-36. PubMed ID: 29775573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
    Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
    Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.
    Mahjoub MA; Bakhshinejad B; Sadeghizadeh M; Babashah S
    Mol Biol Rep; 2017 Aug; 44(4):341-351. PubMed ID: 28752270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
    Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
    J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
    Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
    Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin.
    Sheu MT; Jhan HJ; Hsieh CM; Wang CJ; Ho HO
    Integr Cancer Ther; 2015 Mar; 14(2):184-95. PubMed ID: 25542609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A p-menth-1-ene-4,7-diol (EC-1) from Eucalyptus camaldulensis Dhnh. triggers apoptosis and cell cycle changes in Ehrlich ascites carcinoma cells.
    Islam F; Khanam JA; Khatun M; Zuberi N; Khatun L; Kabir SR; Reza MA; Ali MM; Rabbi MA; Gopalan V; Lam AK
    Phytother Res; 2015 Apr; 29(4):573-81. PubMed ID: 25583285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
    Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
    Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
    Shi J; Li J; Li J; Li R; Wu X; Gao F; Zou L; Mak WWS; Fu C; Zhang J; Leung GP
    Phytomedicine; 2021 Jan; 81():153408. PubMed ID: 33234363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
    Jin J; Sun H; Wei H; Liu G
    Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells.
    Shi Y; Yu Y; Wang Z; Wang H; Bieerkehazhi S; Zhao Y; Suzuk L; Zhang H
    Oncotarget; 2016 Nov; 7(45):73697-73710. PubMed ID: 27655642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway.
    Alkhalaf M; El-Mowafy A; Renno W; Rachid O; Ali A; Al-Attyiah R
    Arch Med Res; 2008 Feb; 39(2):162-8. PubMed ID: 18164959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.